Accuity vs Iodine Software
Two Revenue Integrity & Pre-Bill Review vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Accuity | Iodine Software | |
|---|---|---|
| Pricing model | Contingency (pay from recoveries) · 60-day pilot, no upfront fees | Enterprise contract (custom) · Custom, scales with beds and modules |
| Speed to go live | Chart data feed plus 60-day pilot | Deep EHR integration, CDI workflow redesign |
| Automation model | Tech-enabled service · AI triage, physician-performed reviews | AI copilot · AI surfaces documentation gaps for CDI teams |
| Built for | Enterprise systems | Enterprise systems |
| Security posture | HITRUST | HIPAA |
| Company maturity | 10 yrs (est. 2016) | 16 yrs (est. 2010) |
| Financial backing | Undisclosed | Acquired by Waystar (2025) |
| Named customers | 1 named | None public |
| Published results | Specific numbers public | Specific numbers public |
| Documented integrations | None documented | 1 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Accuity if you want guaranteed inpatient revenue capture from a physician-staffed service rather than another tool for your own team.
- Pick Iodine Software if you're an inpatient health system losing revenue to documentation gaps and want proven AI prioritizing your CDI team's work, now inside Waystar.
Accuity
Physician-led pre-bill chart review that recovers earned revenue
- Founded
- 2016
- HQ
- Mount Laurel, NJ
- Stage
- n/a
- Raised
- n/a
What it does
- Post-discharge, pre-bill second-level chart review
- Amplifi AI trained on 7M+ chart outcomes
- 185 multi-specialty physicians review flagged cases
- DRG, CC/MCC, and quality metric capture
- Medicaid expertise across 38 states
- Compliance oversight with 1.5% final denial rate
Where it's strong
- Runs after your CDI and coding teams finish, so it adds a safety net without changing their workflow.
- Scale is proven: 400+ hospital sites, 4 of the top 10 US health systems, and $3.3B in client revenue lift.
- Performance-based pricing with a 60-day pilot and no upfront fees keeps buyer risk low.
What buyers should weigh
- It is a service engagement, not software your team operates, so capability does not transfer in-house.
- Fees come out of recovered revenue, which costs more at scale than licensing a tool.
- Focused on inpatient pre-bill review; it does not address front-end or denial workflows.
Named customers
Temple Health
Iodine Software
Clinical AI for documentation integrity and utilization review
- Founded
- 2010
- HQ
- Austin, TX
- Stage
- Acquired by Waystar (2025)
- Raised
- n/a
What it does
- AI-prioritized clinical documentation integrity reviews (AwareCDI)
- Utilization management and medical necessity review (AwareUM)
- Physician query workflows
- Revenue leakage detection before billing
- Denial prevention through documentation accuracy
Where it's strong
- Clinical AI trained on one of the industry's largest datasets, covering more than a third of US inpatient discharges.
- Proven at scale, with more than 900 hospitals using AwareCDI and over $1.5B in earned revenue captured.
- Waystar ownership connects its clinical intelligence to a large healthcare payments platform serving about one million providers.
What buyers should weigh
- Post-acquisition roadmap and pricing now sit inside Waystar, which may matter if you use a competing clearinghouse or RCM vendor.
- Built for inpatient hospital workflows; it is not aimed at ambulatory practices or physician groups.
- CDI and UM programs still need trained clinical staff; the software prioritizes work rather than eliminating it.
Integrations
Compare against the rest of Revenue Integrity & Pre-Bill Review
Deciding between these two?
First Pass tracks Revenue Integrity & Pre-Bill Review every week: funding, launches, and what changed since this page was written.